Division of Cardiovascular Medicine

Vanderbilt University Medical Center was recently named a center of excellence for hypertrophic cardiomyopathy by the Hypertrophic Cardiomyopathy Association.

Vanderbilt research shows that genetic testing in patients with early-onset atrial fibrillation can identify variants associated with more serious cardiomyopathy and arrhythmia syndromes that may otherwise remain undiagnosed.

Vanderbilt's JoAnn Lindenfeld, MD, has received the Pioneer Award from the Heart Failure Society of America (HFSA) for being an innovator and pioneer in the field of heart failure.

Vanderbilt's Lynne Warner Stevenson, MD, has received  the Lifetime Achievement Award from the Heart Failure Society of America.

Jane Freedman, MD, has joined Vanderbilt University Medical Center as director of the Division of Cardiovascular Medicine and physician-in-chief of the Vanderbilt Heart and Vascular Institute.

Vanderbilt researchers have discovered new details of the regulation of fat cell metabolism, findings that are important for combating obesity.

Vanderbilt researchers have discovered a potential way to reduce atherosclerosis: blocking the modification of an HDL-associated enzyme by reactive molecules called isolevuglandins.